New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

The study included 12 patients who suffer from a subset of Type 1 diabetes known as hypoglycemic unawareness, characterized ...

WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...

Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.

GLP-1 agonists are already under study for various health benefits beyond diabetes management, such as reducing heart disease risks and treating neurological conditions like Alzheimer's.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 percent lower in patients who took semaglutide compared to those who took ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...